强生公司近日宣布,将以每股335.00美元,总计约131亿美元收购心血管设备制造商Shockwave Medical,此举旨在借助Shockwave的血管内碎石技术,加强其在医疗科技领域的影响力。强生计划通过现金和债务筹集资金,预计交易将于2024年中完成。尽管收购初期可能导致公司2024年和2025年的每股收益分别减少约0.10美元和约0.17美元,但长期来看...
November 6, 2024 By Andy Studna, Senior Editor News Article Trial data over 30 days showed the novel Intravascular Lithotripsy catheter safely modified calcium, enabling effective treatment. Image Credit: © Tamara - stock.adobe.com Shockwave Medical, part of Johnson & Johnson MedTech,...
NEW BRUNSWICK, N.J. and SANTA CLARA, Calif., April 5, 2024– Johnson & Johnson (NYSE: JNJ) and Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave”) today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of S...
ShockWave Medical ( SWAV ) 在今天值得关注的的IBD 50 股票中,在下周公布收益之前接近买入点。 位于加州圣克拉拉的Shockwave公司开发产品,帮助改变钙化心血管疾病的治疗方法。例如,它的碎石工具使用一系列电脉冲来“破裂”血管中的硬化钙。 业界已经注意到了。今年早些时候,美国联邦医疗保险和医疗补助服务中心(Centers ...
Johnson & Johnson MedTech‘s Shockwave Medical announced the U.S. launch of its Javelin peripheral intravascular lithotripsy (IVL) catheter.
Dividend Stock News REITs Dividend Ideas Dividend Strategy Dividend Quick Picks Editors' Picks Analysis by Sector Energy Communication Services Real Estate Consumer Staples Tech Basic Materials Healthcare Consumer Utilities Financials Industrials Stock Comparison Tools FAANG Stocks Gold ETFs Cash Equivalents Bi...
Entering text into the input field will update the search result below Create a free account to read the full article